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Cerebral Glutamine/Glutamate Interrelationships
and Metabolic Compartmentation
S. BERL1 and D. D . CLARKE2

Introduction

The fact that in animals the concentration of glutamate and glutamine are higher
in brain than in any other tissue initially attracted interest in attempting to
understand the function or functions of these amino acids in the central nervous
system. They were evidently required for protein synthesis and early studies
established their close relationship to the Krebs tricarboxylic acid cycle and
energy metabolism in brain. Glutamine for~ation in brain was also shown to be
sensitive to elevations in plasma ammonia levels and to serve as the primary
method for detoxifying this substance in brain in contrast to urea formation in
liver. Also noted was the interesting observation that the increased levels of
glutamine that occurred in hepatic encephalopathy was not accompanied by a
concomitant decrease in glutamic acid levels. The level of these two amino acids
were apparently not tightly coupled despite high levels of glutamine synthetase
activity in brain and glutamic acid is the only established immediate precursor of
glutamine. In recent years increasing evidence pointed to the probability that
glutamic acid also functions as an excitatory neurotransmitter in the central
nervous system. It appears that glutamate serving these various functions is
compartmented into pools of different sizes which turn over at different rates
and are not in rapid equilibrium with each other.
Studies with [14C]-Labeled Amino Acids

Early studies showed that raising the circulating level of glutamate or glutamine
30-50 times did not significantly elevate the brain level of glutamic acid
(Schwerin et al. 1950). This indicated a marked blood-brain barrier to the entry
of glutamate from the circulation. Other organs, e.g., liver and kidney, did not
show this penetrance barrier to glutamate.
Administration of [U14C]-L-Glutamic Acid Intravenously
When 14C-labeled glutamate, glutamine, and aspartate became available similar
experiments were repeated with tracer doses of the amino acids which did not
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alter significantly their physiological levels in the plasma (Lajtha et al. 1959).
The presence of a blood-brain barrier to entry of glutamate from the circulation
was confirmed in these experiments (Table 1). Only a small amount of labeled
amino acid was found in the brain. The liver and kidney were much more
proficient in their uptake of labeled glutamate from the circulation and the
glutamate was also converted to glutamine. It was noted that frequently,
particularly at the earlier time points, the plasma glutamine was of higher
specific activity than that of the glutamate and glutamine in these tissues. Since
liver is a major source of plasma metabolites , in other experiments the liver was
Table 1. Administration of [U-14C]-L-glutamic acid i.v. into mice
Timea
(min)

Organ

Specific activityb
Glutamic acid

Glutamine

2

Plasma
Brain
Liver
Red blood cells
Kidney

29,000
50
2,000
1,900
700

3,600
35
1,300
220
390

5

Plasma
Brain
Liver

14,000
93
2,400

3,000
57
2,000

10

Plasma
Brain
Liver

8,000
920
9,200

3,000
230
11,000

•

Each time point is the average of two experiments. Four adult mice were used for each
experiment. 0.1 ml [U- 14C]-glutamic acid was injected. Each animal received 0.5 f..LCi and 7 !lg
glutamic acid corresponding to 30% of the plasma glutamic acid content
b Specific activity: cpm/f..Lmol

a

Table 2. Administration of [U- 14C]-L-glutamic acid i. v. into rats with restricted circulation a
Organ

Specific activityb
Glutamic acid

Glutamine

Unrestricted circulation

Plasma
Red blood cells
Lung
Heart
Muscle (front legs)
Brain

520,000
27,000
68 ,000
7,800
3,800
300

38,000
8,200
34,000
5,300
2,000
550

Restricted circulation

Liver
Kidney
Muscle (hind legs)

1,800
17
100

790
190
54

The inferior vena cava and the abdominal aorta were tied off in rats and 0.1 m1 14C glutamic acid
(5 f..LC; 1 f..Lmol) was injected into the subclavian vein, and the animals sacrified after 5 min
b Specific activity: cpm/f..Lmol

a

•
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largely eliminated from the circulation by tying off the inferior vena cava and the
abdominal aorta in rats (Lajtha et al. 1960). When labeled glutamate was
administered i.v., the plasma glutamine was again higher in specific activity
(counts/min/J.Lmol; SA) than any other organ examined (Table 2) . The specific
activities of the lung glutamate and glutamine were higher than in other organs.
Whether or not the lung glutamine equilibrates rapidly with plasma glutamine or
is the source of plasma glutamine, remains unknown. The data suggested that
glutamine was being formed from glutamate in an organ or organs and rapidly
released to the plasma before mixing with the total glutamine of the organ. This
compartmentation of glutamate to glutamine metabolism was suggested as
occurring in organs other than brain even before studies established its presence
in brain.
Administration of (U- 14C]-L-Glutamic Acid Intracisternally
Since our interests centered mainly on brain metabolism we decided to bypass
the blood-brain barrier and administered the labeled glutamate into the
cerebrospinal fluid via the cisterna magna (Berl et al. 1961). After short intervals
of time following injection of the [U- 14C]-L-glutamate, blood plasma, liver and
brain were analyzed for labeled glutamic acid and glutamine (Table 3). The
radioactivity in these two amino acids in brain and liver were very different from
that in the plasma and did not equilibrate with the plasma amino acids. The brain
glutamine SA was greater than that of the plasma glutamine at all time points,
even at 1 min; therefore, the labeled glutamine in the brain must have been
synthesized there and not derived from the blood . The conversion of glutamate
to glutamine was very rapid in the brain. By 1 min the relative specific activity
(RSA) of the glutamine (glutamate = 1) was greater than 1 and reached values
of 5 by 5 min. During this time period, the SA of glutamate decreased, while that
of glutamine increased, although the sum of the counts in these two amino
acids/g of fresh tissue remained relatively constant; the radioactivity was
redistributed between the glutamate and glutamine. It is theoretically not
probable for contributions of glutamate and glutamine from other sources, such
as protein metabolism, carbohydrate metabolism, or citric and cyclic metabolites
to explain the fivefold difference between the SA activity of glutamate and
glutamine (Berl et al. 1961). The explanation offered was that the higher SA of
brain glutamine relative to that of glutamate resulted from the conversion of a
small pool or compartment of glutamate of high SA to glutamine. Extraction of
the tissue would dilute this pool by the total amount in the tissue to a value less
than that of the glutamine. It would have been anticipated that in a more
homogeneous product-precursor system, the SA of the precursor glutamate
would fall , while that of the product glutamine would rise and equal or slightly
rise above that of glutamate, but no exceed it by fivefold (Reiner 1953). The liver
showed a more conventional product-precursor relationship of glutamine to
glutamate, although in this organ as well metabolic compartmentation of these
metabolites is also very likely, as discussed later. Upon intracisternal injection of
the 14C-glutamic acid, the labeled amino acid was present throughout the brain
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Table 3. Administration of [U- 14C]-L-glutamic acid intracisternally in the rat

Time
(min)

Substratesa

SA
Plasma

1

GA
Gm

180,000
1,200

2

GA
Gm

5

Brain

Brain

Total
GA+Gm

0.43

77,000
15,000

92,000

200
66

5,500
7,300

1.3

51,000
33,000

84,000

130,000
2,200

800
600

3,200
12,000

3.8

32,000
59,000

91,000

GA
Gm

34,000
6,100

700
760

2,700
14,000

5.2

27,000
70,000

97,000

15

GA
Gm

8,900
6,500

190
280

2,200
11,000

5.0

22,000
55,000

77,000

30

GA
Gm

3,300
870

180
240

2,100
7,300

3.5

21,000
37,000

58,000

60

GA
Gm

1,500
140

61
130

1,900
5,000

2.6

19,000
25,000

44,000

b

GA
Gm

Liver

Total counts/g tissueb

7,700
3,300

a

0.25

RSA
Brain

SA: Specific activity (cpm/~ol)~ GA: glutamine acid; Gm: glutamine; RSA: relative specific
. .
Gm
actiVIty=GA
Results are the average of two experiments. In each experiment, two rats were injected via the
cisterna magna with (U- 14C]-L-glutamatic acid (0.02 ml; 40 j..tCi, 4 ~-tmoVml in normal saline)

Table 4. Administration of [U- 14C)-L-glutamic acid intracisternally in the rat: area metabolism

Brain area

SA/GAa

Gm

RSA/GSHb

GABA

Cerebrum
Cerebellum
Pons medulla

2,065
7,000
14,000

4.3
5.3
5.0

1.1
1.0
1.1

0.21
0.34
0.23

a See Table 3 for abbreviations and experimental conditions. Rats were killed after 2 min. Average
of four experiments
b GSH: glutathione

and rapidly converted to glutamine as well as other metabolites, such as
glutathione and GABA (Berl et al. 1961, Table 4). The radioactivity was highest
in the cerebellum and brain stem, the areas closest to the site of injection. The
RSA of glutamine (relative to that of glutamate) was approx. 4-5, that of the
glutamate in glutathione approx. 1 and that of GABA approx. 0.2-0.3. An
experiment of the same type in a monkey showed similar results in 14 brain areas
and the spinal cord (Berl et al. 1961).
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Table 5. Administration of [U- 14C]-L-glutamine intracisternally in the rat: area metabolism

RSA

Brain area

Cerebrum
Cerebellum
Pons medulla
a

Gm

GA

GSH

GABA

4,980
9,900
12,000

418
860
930

1.6
1.7
2.2

0.7
0.9
0.6

See Tables 3 and 4 for experimental details and abbreviations. Animals killed 2 min after injection
of U- 14 C-L-glutamine (0.02 ml; 50 ~-tCi , 12 ~-tmollml in normal saline). Average of three
experiments, two animals per experiment

Administration of [U-14C]-L-Glutamine Intracisternally
Labeled glutamine was injected into the cisterna magna of rats and after 2 min
the animals were killed and glutamine, glutamic acid , glutathione (glutamic
acid) , GABA, and aspartic acid were isolated and counted (Berl et al. 1961,
Table 5). In these experiments , the SA of the glutamine was considerably higher
than that of glutamate. However, the RSAs of glutathione and GABA were
higher than those in the experiments in which labeled glutamate was the
administered tracer (compare with Table 4). The radioactivity in the aspartate
was similar to that in the GABA (data not shown). The data suggested that
glutamine may serve as a source of glutamate which can form GSH or GABA
better than administered glutamate. This early data may be of particular
significance in the light of more recent suggestions that formation of glutamine in
brain tissue may function to neutralize glutamate released as a neurotransmitter
at synaptic clefts and also to conserve the carbon skeleton for use again as
transmitter glutamate or GABA (Bradford et al. 1978, Hamberger et al.
1979a, b).
Administration of [U-14C]-L-Aspartic Acid Intracisternally
Following the injection of labeled aspartic acid into the cisterna magna of rats,
the label quickly appeared in glutamic acid and its metabolites (Berl et al. 1961,
Table 6). The pattern which emerged was similar to that following administration of radioactive tracer glutamate; the RSA of glutamine was approx. 4-5.0
throughout the brain, that of GABA 0.1 - 0.2 and that of GSH 0.2-0.5. The
brain asparagine was also significantly labeled, but its SA relative to that of
aspartic acid was quite low 0.01-0.02. As anticipated (Goldstein 1959), N-acetyl
aspartic acid had only trace amounts of radioactivity (data not included).
With aspartate as the labeled tracer, if the metabolic pattern was that of an
homogeneous system, it would have been anticipated that as the SA of the
glutamate rose that of the glutamine would also rise, but at a slower rate and
eventually equal or slightly exceed that of the glutamic acid (Reiner 1953). The
measured RSA value of approx. 5 was again explained by the proposal that the
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Table 6. Administration of (U- 14C)-L-aspartic acid intracisternally in the rat: area metabolism

Brain area

Cerebrum
Cerebellum
Pons medulla
Whole brain
a
b

SAa

RSAb

AA

GA

Asn

Om

GABA

GSH

37,000
160,000
70,000
55,000

1,110
3,400
4,500
1,600

0.02
0.02
0.01
0.02

4.7
4.7
4.0
5.0

0.10
0.20
0.07
0.11

0.37
0.52
0.20
0.36

See Tables 3 and 4 for experimental details and abbreviations
Asn: asparagine; AA: aspartic acid
RSA 0 fAsn =SAofAsn
SA of AA
Animals killed 2 min after injection of (U- 14C]-L-aspartic acid (0.02 ml; 50 JJ.Ci, 10 J-Lmol/ml in
normal saline)

newly formed glutamate from the administered aspartate mixed with only a
portion of the total tissue glutamate which was the source of labeled glutamine.
When the total tissue content of the amino acids was extracted, the radioactivity
in the glutamate was greatly reduced by unlabeled glutamate and its SA
measured as less than that of the glutamine.

Ammonia Metabolism

The increased levels of ammonia and glutamine that occur in hepatic coma
(Gilon et al. 1959) and in animals with porto-caval anastomosis or hepatectomy
(Flock et al. 1953, Bollman et al. 1957) points to a close association between
ammonia and glutamine/glutamate metabolism. Therefore, the administration
of toxic levels of ammonia was utilized for a study of the role of these amino acids
in detoxification of ammonia in vivo and for further understanding of the
relationship between ammonia metabolism and glutamate-glutamine metabolic
compartmentation (Takagaki et al. 1961, Berl et al. 1962a).
Administration of [15N]-Ammonium Acetate in the Cat Intraarterially
In this set of experiments, [15N]-ammonium acetate was administered into the
carotid artery of the cat at a constant rate for periods of time up to 25 min. The
results were, therefore, obtained by a constant feed of label rather than by pulse
labeling. The data reflected accumulation of the labeled metabolites rather than
decay as in the previous experiments.
The results of a representative experiment in which the 15NH3 was infused for
20 min is shown in Table 7. In the blood, brain, and liver, the ammonia
concentration was markedly elevated (20-fold or more) , but the 15N concentration in the free ammonia was less than that in the administered ammonium
acetate. This indicated a rapid dilution of the administered labeled ammonia by
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Table 7. Administration of
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15

N-ammonium acetate into the cartoid artery of the cat

Cerebral cortex

Blood

Liver

~mollg

tsN

~mollg

l5N a

~mollg

15N

Ammonia

6.7

65

6.2

81

13.3

81

Glutamine
Amide
a-Amine

9.6
9.6

44.9
12.8

0.43
0.43

13.7
2.7

1.3
1.3

26.1
6.4

Glutamic acid

9.1

1.6

0.09

9.9

2.7

35.2

Aspartic acid

2.1

1.0

0.05

9.6

4.0

46.1

GABA

1.3

1.5

Urea

5.5

1.3

5.9

11.2

6.3

17.5

Glutathione

1.8

0.43

4.8

2.3

a 15N

Ammonium acetate (99.6 atom % excess, 1 mmollml) was infused at a constant rate of
1 ml/min for 20 min. 15N data expressed as atom % excess

the tissue ammonia, probably as a result of tissue metabolism. In the cerebral
cortex , following free ammonia, the highest concentration of 15N was in the
amide group of glutamine followed by that in the a -amino groups of glutamine.
The latter was approximately eight times greater than the 15N concentration in
the a-amino nitrogen of glutamic acid. Since glutamine is synthesized directly
from glutamic acid, the labeled brain glutamine must have been derived from a
pool or compartment of brain glutamic acid that did not exchange or equilibrate
readily with the total tissue glutamic acid. The 15N concentrations in the amide
and a-amino moieties of brain glutamine were higher than in the glutamine
isolated from blood or liver and, therefore, it was made in the brain and not
derived from the blood. The a-amino nitrogen concentration of the brain
glutamine was also above that present in the blood glutamic acid; the latter could
not have been a source of the former. Lesser amounts of 15N were also present in
brain aspartic acid, GABA, glutathione (glutamic acid), and urea. The 15N level
in the brain urea was much below that in the blood or liver urea and could have
been derived from the blood. Urea is not a major pathway for ammonia
detoxification in brain.
The data suggest that in brain, glutamate dehydrogenase is associated with
the formation of the small pool of glutamic acid preferentially used in the
formation of glutamine , since this enzyme is responsible for the direct
incorporation of ammonia into a-ketoglutarate to form glutamic acid.
The distribution of 15NH3 in liver metabolites is very different than that in
brain. In this organ the 15N content in glutamic acid was higher than in the
a-amino or amide moiety of glutamine . In fact, it was the aspartic acid which was
most highly labeled with 15N (next to free ammonia). The a-amino group is
introduced into aspartic acid by transamination of oxaloacetic with glutamic acid
or perhaps glutamine. Therefore , in liver, there may be pools of highly labeled
glutamic acid or glutamine or both that do not exchange rapidly with the
•
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remainder of the liver glutamate or glutamine, but transaminate preferentially
with oxaloacetate. These pools may be associated more directly with urea
formation which is the major pathway for ammonia detoxification in the
liver.
Other investigators, in a study of ammonia metabolism in brain, infused
radioactive [1 3N]-ammonia via the carotid artery of the rat (Cooper et al. 1979).
In those studies, trace amounts of ammonia were administered and the
physiological level was not altered. Their results essentially corroborated ours
and were consistent with the interpretation that ammonia entering the brain
from the blood was metabolized in a small pool of glutamate that was turning
over very rapidly and distinct from a larger tissue pool of glutamate.

Carbon Dioxide Fixation in Brain

The results of the ammonia infusion experiments demonstrated, as had been
reported previously (Flock et al. 1953, Bollman et al. 1957), that elevated
ammonia levels lead to increased levels of glutamine without a corresponding
decrease in glutamic acid in brain. If the synthesis of glutamic acid required for
the synthesis of the newly formed glutamine was to occur without drastic
depletion of the intermediates of the Krebs' tricarboxylic acid cycle 4-carbon
units of the cycle had to be replenished. In liver, members of the Krebs cycle are
formed by fixation of C0 2 to pyruvate or phosphoenolpyruvate to form malate
and oxaloacetate. Therefore, studies were undertaken to evaluate the extent of
C02 fixation in brain tissue (Berl et al. 1962b, Waelsch et al. 1964).
Administration of [14C]-Sodium Bicarbonate Intravenously
14C-labeled

sodium bicarbonate was injected at a constant rate for time periods
of up to 18 min via the inferior vena cava in the cat. A representative experiment
is shown in Table 8. The aspartic acid, glutamic acid, and glutamine isolated
from both liver and brain were labeled. The radioactivity in aspartic acid in both
organs was higher than that in glutamic acid or glutamine. This was to be
expected if in both organs C02 was fixed at the oxaloacetate or malate level.
However, the pattern of labeling of glutamate and glutamine was different in
these two organs. In brain, the glutamine had a higher specific activity than
glutamic acid; the opposite occurred in the liver. This again was in accord with
the conclusion that in brain a small pool of glutamic acid was preferentially
directed toward the formation of glutamine, whereas in liver, glutamine was
formed from a large compartment of glutamic acid. The rate of C02 fixation in
brain was somewhat more than 10% of that in liver, the major C02 fixing
organ.
Since a-ketoglutarate served as a precursor for the glutamic acid it would
have been expected to have contained considerably higher radioactivity than
glutamate or glutamine in brain and liver. In brain, the high SA of glutamine
relative to that of a-ketoglutarate (Tables 8 and 9) pointed to the conclusion that
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Table 8. Administration of [1 4C]-sodium bicarbonate into the inferior vena cava of the cat8
Liver

Brain

Glutamic acid
Glutamine
Aspartic acid
a-Ketoglutarate
Pyruvate
Tissue C02
14
C02 fixed
a

~ollg

SA

10.2
5.7
2.3

890
1,640
7,110
1,070
820
29,000

14.2
1.63

SA

Jlrnollg
3.4
2.8
0.7

16,910
5,180
43,360
6,250
1,800
25,000

13.4
13.0

1.7 ml of bicarbonate solution (0.06 M; 0.29 mCi/ml in saline) was given i.v. during the first 10 s to
bring the specific activity of the blood C02 rapidly to a precalculated level. Infusion was continued
at the rate of 0.2 ml/min for 18 min. SA: Specific activity, cpm/JlmOl

Table 9. Administration of [l4C]-sodium bicarbonate and ammonium acetate into the inferior vena
cava of the cat3
Brain

Glutamatic acid
Glutamine
Aspartic acid
a-Ketoglutarate
Pyruvate
Tissue C02
NH3
a

JliDOl/g

SA

10.4
7.3
2.1

1,520
7,860
5,900
3,190
840
55,000

11.4
6.9

The ammonium acetate was administered as a 2.5 M solution containing NaH 14 C03 (0.06 M;
0.29 mCi/ml). This solution was infused at a rate of 0.2 mllmin for 15.5 min immediately following
the injection of the 1.7 ml of the bicarbonate solution (see Table 8)

the keto acid in brain was divided into at least two pools, one of which was more
highly labeled and associated with rapid glutamine formation. In liver, this keto
acid was of much lower SA than glutamate which suggested the presence of a
small pool of labeled keto acid of high SA from which glutamate was derived.
Such compartmentation of pools of a-ketoglutarate indicated the existence of at
least two separate Krebs cycles in brain (Gaitonde 1965). The above data
suggested that the same may be true in liver.
Administration of [1 4C]-Sodium Bicarbonate
and Ammonium Acetate Intravenously
In cats in which 14C-sodium bicarbonate and ammonium acetate were given
together via the inferior vena cava, the labeling pattern of the amino acids was
altered in brain, predominantly in favor of the incorporation of label into newly
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formed glutamine. The glutamine achieved the highest SA, approximately five
times greater than that of glutamic acid and also higher than that of aspartic acid.
The data suggested that in the presence of elevated levels of tissue ammonia,
oxaloacetate formed by C02 fixation was preferentially utilized for the
formation of a-ketoglutarate and in turn of glutamate to be converted to
glutamine. Calculation of the amount of C02 incorporated into the amino acids
in brain in the presence or absence of increased ammonia levels indicated that in
the former condition the rate of C02 fixation was increased, almost all in
glutamine, as compared to the latter condition (Waelsch et al. 1964,
Ber11971).

In Vitro Studies

In the study of whole animals, the question was often raised as to the
contribution of other organs to the pattern of metabolic compartmentation seen
in brain. This led to the study of metabolic compartmentation in brain slice
preparations (Berl and Clarke 1969). Using isotopically labeled glutamate,
aspartate, bicarbonate, acetate, leucine, and other precursors , the metabolic
picture described above in living animals was confirmed. Hence, there could be
no doubt that this compartmentation of glutamate-glutamine metabolism seen in
brain was characteristic of this tissue.

Location of the Compartments

This chapter presents some of the data on which the conclusion is based that
metabolites are separated into pools or compartments within the tissue. In brain,
one is faced with a very complex mixed cell population of several different types
of glia and neurons and their axonal and dendritic extensions as well as possibly
different populations of mitochondria. Compartmentation of the glutamate-glutamine systems has never been demonstrated in brain tissue homogenates.
Therefore, such phenomena are very likely to be associated with anatomical
cellular differentiation.
Most of the data can be explained by the very oversimplified assumption of
two or three cellular compartments. Based on a large variety of data, the small
pool of glutamate active in glutamine formation has been placed in the astrocytic
glia, the large pool of glutamate in the neurons, and perhaps a subpool of the
larger pool in nerve endings (Balazs et al. 1973). Developmental studies support
such a localization since the evidence for metabolic compartmentation begins to
be manifested during the development of the neuronal cell bodies , their axons,
and dendrites (Berl1965, Patel and Balazs 1970), marking the development of
the large compartment. However, glial development is also present during this
period.
Based on the metabolic studies, it would be anticipated that the small pool
would be associated with glutamine synthetase, glutamate dehydrogenase, and
with acetyl-CoA synthetase, the enzyme that converts acetate to acetyl-CoA
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(acetate is also preferentially metabolized to glutamine in the small compartment) (Berl and Frigyesi 1969). In animals in which ammonia was injected or
hepato-portal shunt performed (Cavanagh 1974) as well as in humans with
hepatic encephalopathy (Cavanagh 1974), it was the astrocytes rather than the
neurons which were most severely affected. In similar animal studies,
histochemical evaluations indicated increased glutamate dehydrogenase activity
localized to the astrocytes (Norenberg 1976). Also, glutamate dehydrogenase
was found to be low in synaptosomes (Neidle et al. 1969, Wilson and Barch 1971)
and nerve cell bodies (Kuhlman and Lowry 1956). Other studies found brain
glutamate dehydrogenase and acetyl-CoA synthetase to be enriched in a fraction
of mitochondria that sedimented in a sucrose gradient more rapidly than the
average of all the mitochondria (Reijnierse et al. 1975). Although there is no
direct evidence of its source, this fraction of mitochondria may be predominantly
from glial cells.
The placement of the small compartment in the glia was greatly enhanced
by the immunohistochemical study in which glutamine synthetase was found to
be localized in the glia and not evident in neuronal cell bodies (MartinezHernandez et al. 1977). Similar immunohistochemical techniques also showed
that rat retina glutamine synthetase was concentrated in the Muller cells, the
glial cells of the retina (Riepe and Norenberg 1977). G. Gambos (personal
communication 1983), using similar methods, found the glutamine synthetase
principally in the Bergmann glial cells of the rat cerebellum.
These many metabolic and anatomic studies provide some of the basis for the
idea that glia function in the uptake and metabolism of exogenous or
extracellular substances, e.g., transmitter amino acids and ammonia. Thus, they
provide protective mechanisms as well as methods for the conservation and
recycling of carbon skeleton and amino nitrogen.
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